Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-furansulfonamide, N-(((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino)carbonyl)-4-(1-hydroxy-1-methylethyl)-
2. Cp-456,773
3. Cp-456773
4. Crid3
5. Mcc-950
6. N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide
1. 210826-40-7
2. Mcc-950
3. Cp-456773
4. Crid3
5. N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-4-(2-hydroxypropan-2-yl)furan-2-sulfonamide
6. Unii-6rs86e2bwq
7. Cp-456,773
8. 6rs86e2bwq
9. Dtxsid2047301
10. 1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[4-(2-hydroxypropan-2-yl)furan-2-yl]sulfonylurea
11. Chembl3183703
12. Dtxcid0027301
13. N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-4-(2-hydroxypropan-2-yl)furan-2-sulfonamide
14. N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-2-furansulfonamide
15. 1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[4-(2-oxidanylpropan-2-yl)furan-2-yl]sulfonyl-urea
16. Mfcd30478884
17. 1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-(4-(2-hydroxypropan-2-yl)furan-2-yl)sulfonylurea
18. 7yn
19. Mfcd28900720
20. Gtpl8228
21. Schembl6521858
22. Chebi:231684
23. Glxc-10741
24. Bcp15729
25. Ex-a1052
26. Tox21_300462
27. Bdbm50155926
28. S8930
29. Akos030238802
30. As-5972
31. Sb19010
32. Ncgc00248064-01
33. Ncgc00254269-01
34. 2-furansulfonamide, N-(((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino)carbonyl)-4-(1-hydroxy-1-methylethyl)-
35. Ac-35299
36. Da-75353
37. Hy-12815
38. N-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide
39. Sy242180
40. Cas-210826-40-7
41. En300-24107374
42. Brd-k55418700-001-02-2
43. Q27083691
44. 1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[4-(2-hydroxypropan-2-yl)furan-2-ylsulfonyl]urea
45. 1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-{[4-(2-hydroxypropan-2-yl)furan-2-yl]sulfonyl}urea
46. 8gi
| Molecular Weight | 404.5 g/mol |
|---|---|
| Molecular Formula | C20H24N2O5S |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 117 |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 684 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
57
PharmaCompass offers a list of Mcc950 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mcc950 manufacturer or Mcc950 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mcc950 manufacturer or Mcc950 supplier.
PharmaCompass also assists you with knowing the Mcc950 API Price utilized in the formulation of products. Mcc950 API Price is not always fixed or binding as the Mcc950 Price is obtained through a variety of data sources. The Mcc950 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mcc950 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mcc950, including repackagers and relabelers. The FDA regulates Mcc950 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mcc950 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mcc950 supplier is an individual or a company that provides Mcc950 active pharmaceutical ingredient (API) or Mcc950 finished formulations upon request. The Mcc950 suppliers may include Mcc950 API manufacturers, exporters, distributors and traders.
Mcc950 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mcc950 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mcc950 GMP manufacturer or Mcc950 GMP API supplier for your needs.
A Mcc950 CoA (Certificate of Analysis) is a formal document that attests to Mcc950's compliance with Mcc950 specifications and serves as a tool for batch-level quality control.
Mcc950 CoA mostly includes findings from lab analyses of a specific batch. For each Mcc950 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mcc950 may be tested according to a variety of international standards, such as European Pharmacopoeia (Mcc950 EP), Mcc950 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mcc950 USP).
